Search research articles
Contact Us
Filters
Showing results (201-210 of 659) with videos related to
Page
of 66
Sort By:
Environment International
|
September 22, 2009
Ricin as a weapon of mass terror--separating fact from fiction
Leo J Schep, Wayne A Temple, Grant A Butt, et al.
The Journal of Infectious Diseases
|
October 8, 2024
COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and Vaccinated
Adeel A Butt, Peng Yan, Abdul-Badi Abou-Samra, et al.
Hepatology (Baltimore, Md.)
|
February 19, 2016
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
Tracey G Simon, Hector Bonilla, Peng Yan, et al.
International Journal of Molecular Sciences
|
June 24, 2022
Subwavelength Grating Waveguide Structures Proposed on the Low-Cost Silica-Titania Platform for Optical Filtering and Refractive Index Sensing Applications
Muhammad A Butt, Cuma Tyszkiewicz, Katarzyna Wojtasik, et al.
The New England Journal of Medicine
|
February 9, 2022
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans
Florian B Mayr, Victor B Talisa, Obaid Shaikh, et al.
Protist
|
February 3, 2022
Effects of Copper and the Insecticide Cypermethrin on a Soil Ciliate (Protozoa: Ciliophora) Community
Hai T T Luu, Genoveva F Esteban, Andrew A Butt, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2006
Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects
A A Butt, A C Justice, M Skanderson, et al.
Alimentary Pharmacology & Therapeutics
|
November 5, 2016
Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES
A A Butt, Y Ren, K Marks, et al.
Alimentary Pharmacology & Therapeutics
|
July 27, 2016
Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES
A A Butt, P Yan, K Marks, et al.
Saudi Medical Journal
|
May 29, 2007
The role of fine needle aspiration cytology in the diagnosis of peripheral lymphadenopathy. An institutional experience of 83 cases
Hussein A Al-Abkari, Sohail A Butt, Abdulghani E Al-Abkari, et al.
Page
of 66
Search research articles
Search
Showing results (201-210 of 659) with videos related to
Sort By:
Page
of 66
Environment International
|
September 22, 2009
Ricin as a weapon of mass terror--separating fact from fiction
Leo J Schep, Wayne A Temple, Grant A Butt, et al.
The Journal of Infectious Diseases
|
October 8, 2024
COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and Vaccinated
Adeel A Butt, Peng Yan, Abdul-Badi Abou-Samra, et al.
Hepatology (Baltimore, Md.)
|
February 19, 2016
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
Tracey G Simon, Hector Bonilla, Peng Yan, et al.
International Journal of Molecular Sciences
|
June 24, 2022
Subwavelength Grating Waveguide Structures Proposed on the Low-Cost Silica-Titania Platform for Optical Filtering and Refractive Index Sensing Applications
Muhammad A Butt, Cuma Tyszkiewicz, Katarzyna Wojtasik, et al.
The New England Journal of Medicine
|
February 9, 2022
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans
Florian B Mayr, Victor B Talisa, Obaid Shaikh, et al.
Protist
|
February 3, 2022
Effects of Copper and the Insecticide Cypermethrin on a Soil Ciliate (Protozoa: Ciliophora) Community
Hai T T Luu, Genoveva F Esteban, Andrew A Butt, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2006
Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects
A A Butt, A C Justice, M Skanderson, et al.
Alimentary Pharmacology & Therapeutics
|
November 5, 2016
Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES
A A Butt, Y Ren, K Marks, et al.
Alimentary Pharmacology & Therapeutics
|
July 27, 2016
Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES
A A Butt, P Yan, K Marks, et al.
Saudi Medical Journal
|
May 29, 2007
The role of fine needle aspiration cytology in the diagnosis of peripheral lymphadenopathy. An institutional experience of 83 cases
Hussein A Al-Abkari, Sohail A Butt, Abdulghani E Al-Abkari, et al.
Page
of 66